NEWS

Biocytogen Launches RenNano® Mouse, a Fully Human Heavy Chain Antibody Platform to Accelerate Nanobody Drug Discovery

2023-01-12

Biocytogen Launches RenNano® Mouse, a Fully Human Heavy Chain Antibody Platform to Accelerate Nanobody Drug Discovery

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. today officially launched its fully human heavy chain antibody platform, RenNano®. RenNano® is the third member of the RenMiceTM family, joining RenMabTM and RenLite®. Together, Biocytogen’s three RenMiceTM platforms allow for the streamlined discovery and development of fully human monoclonal antibodies, bispecific/multispecific antibodies and...